Jump Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-215,600
| Closed | -$707K | – | 1784 |
|
|
2024
Q2 | $707K | Buy |
+215,600
| New | +$707K | 0.01% | 969 |
|
|
2023
Q3 | – | Sell |
-362,053
| Closed | -$1.72M | – | 1960 |
|
|
2023
Q2 | $1.72M | Buy |
362,053
+104,653
| +41% | +$498K | 0.06% | 449 |
|
|
2023
Q1 | $1.47M | Buy |
257,400
+163,911
| +175% | +$934K | 0.06% | 461 |
|
|
2022
Q4 | $943K | Buy |
93,489
+2,979
| +3% | +$30.1K | 0.05% | 507 |
|
|
2022
Q3 | $2.03M | Sell |
90,510
-1,610
| -2% | -$36.1K | 0.08% | 379 |
|
|
2022
Q2 | $2.28M | Buy |
92,120
+45,102
| +96% | +$1.12M | 0.1% | 275 |
|
|
2022
Q1 | $1.82M | Buy |
+47,018
| New | +$1.82M | 0.08% | 318 |
|
|
2021
Q4 | – | Sell |
-30,121
| Closed | -$1.79M | – | 1484 |
|
|
2021
Q3 | $1.79M | Buy |
+30,121
| New | +$1.79M | 0.13% | 174 |
|